InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Patel Naimish. Director active across 1 company, notably CRISPR Therapeutics AG. Aggregated, 6 reports have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €351k. History available since 29 May 2025. The latest transaction was disclosed on 29 May 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Patel Naimish is a declarant linked to CRISPR Therapeutics AG, where the listed role is Chief Medical Officer. There are 4 filings in total in the data, and among the sampled recent filings, the transactions run from 2026-01-27 to 2026-06-01, with EUR 45006.1859523903 of buys and EUR 181307.0806034446 of sells; the modal transaction nature is Levée d'options.